BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 22918865)

  • 1. The fungicide fludioxonil antagonizes fluconazole activity in the human fungal pathogen Candida albicans.
    Buschart A; Burakowska A; Bilitewski U
    J Med Microbiol; 2012 Dec; 61(Pt 12):1696-1703. PubMed ID: 22918865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates.
    Holmes AR; Lin YH; Niimi K; Lamping E; Keniya M; Niimi M; Tanabe K; Monk BC; Cannon RD
    Antimicrob Agents Chemother; 2008 Nov; 52(11):3851-62. PubMed ID: 18710914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance.
    Niimi M; Niimi K; Takano Y; Holmes AR; Fischer FJ; Uehara Y; Cannon RD
    J Antimicrob Chemother; 2004 Dec; 54(6):999-1006. PubMed ID: 15486081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of fluconazole resistance in Candida albicans isolates from Japanese AIDS patients.
    Maebashi K; Niimi M; Kudoh M; Fischer FJ; Makimura K; Niimi K; Piper RJ; Uchida K; Arisawa M; Cannon RD; Yamaguchi H
    J Antimicrob Chemother; 2001 May; 47(5):527-36. PubMed ID: 11328762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonism of azole activity against Candida albicans following induction of multidrug resistance genes by selected antimicrobial agents.
    Henry KW; Cruz MC; Katiyar SK; Edlind TD
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1968-74. PubMed ID: 10428921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Major Efflux Pumps in Fluconazole-Resistant Candida albicans.
    Pourakbari B; Teymuri M; Mahmoudi S; Valian SK; Movahedi Z; Eshaghi H; Mamishi S
    Infect Disord Drug Targets; 2017; 17(3):178-184. PubMed ID: 28558643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifungal effect of Echinophora platyloba on expression of CDR1 and CDR2 genes in fluconazole-resistant Candida albicans.
    Khajeh E; Hosseini Shokouh SJ; Rajabibazl M; Roudbary M; Rafiei S; Aslani P; Farahnejad Z
    Br J Biomed Sci; 2016; 73(1):44-8. PubMed ID: 27182677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fcr1p inhibits development of fluconazole resistance in Candida albicans by abolishing CDR1 induction.
    Shen H; An MM; Wang de J; Xu Z; Zhang JD; Gao PH; Cao YY; Cao YB; Jiang YY
    Biol Pharm Bull; 2007 Jan; 30(1):68-73. PubMed ID: 17202662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India.
    Mane A; Vidhate P; Kusro C; Waman V; Saxena V; Kulkarni-Kale U; Risbud A
    Mycoses; 2016 Feb; 59(2):93-100. PubMed ID: 26648048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of iprodione and fludioxonil on glycerol synthesis and hyphal development in Candida albicans.
    Ochiai N; Fujimura M; Oshima M; Motoyama T; Ichiishi A; Yamada-Okabe H; Yamaguchi I
    Biosci Biotechnol Biochem; 2002 Oct; 66(10):2209-15. PubMed ID: 12450134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D; Coste AT
    Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Function and gene expression of the active efflux transporters in drug-resistant Candida albicans].
    Guo HJ; Xia ZD; Wu GL; Zhou H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 32(1):183-7. PubMed ID: 17344615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Investigation of mutations in transcription factors of efflux pump genes in fluconazole-resistant Candida albicans strains overexpressing the efflux pumps].
    Kalkandelen KT; Doluca Dereli M
    Mikrobiyol Bul; 2015 Oct; 49(4):609-18. PubMed ID: 26649419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Investigation of the expression levels of efflux pumps in fluconazole-resistant Candida albicans isolates].
    Gulat S; Doluca Dereli M
    Mikrobiyol Bul; 2014 Apr; 48(2):325-34. PubMed ID: 24819270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic Organotellurium Compounds Sensitize Drug-Resistant Candida albicans Clinical Isolates to Fluconazole.
    Reis de Sá LF; Toledo FT; Gonçalves AC; Sousa BA; Dos Santos AA; Brasil PF; Duarte da Silva VA; Tessis AC; Ramos JA; Carvalho MA; Lamping E; Ferreira-Pereira A
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance.
    Tsao S; Rahkhoodaee F; Raymond M
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1344-52. PubMed ID: 19223631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ABC transporter BcatrB from Botrytis cinerea is a determinant of the activity of the phenylpyrrole fungicide fludioxonil.
    Vermeulen T; Schoonbeek H; De Waard MA
    Pest Manag Sci; 2001 May; 57(5):393-402. PubMed ID: 11374155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cetylpyridinium chloride resistance and treatment on fluconazole activity versus Candida albicans.
    Edlind MP; Smith WL; Edlind TD
    Antimicrob Agents Chemother; 2005 Feb; 49(2):843-5. PubMed ID: 15673785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eucalyptal D Enhances the Antifungal Effect of Fluconazole on Fluconazole-Resistant
    Xu J; Liu R; Sun F; An L; Shang Z; Kong L; Yang M
    Front Cell Infect Microbiol; 2019; 9():211. PubMed ID: 31281800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum repressing efflux pump CDR1 in Candida albicans.
    Yang YL; Lin YH; Tsao MY; Chen CG; Shih HI; Fan JC; Wang JS; Lo HJ
    BMC Mol Biol; 2006 Jul; 7():22. PubMed ID: 16839415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.